Equity

AI-powered drug development, VW teams up with Rivian, and DEI is 'bad'

Jun 28, 2024
Dive into the dramatic world of tech with discussions on an AI-driven drug development startup securing $372 million in funding. Explore Volkswagen's bold $1 billion partnership with Rivian that could skyrocket to $5 billion. Discover the rise of the fediverse, a decentralized social media revolution gaining traction post-Twitter's transition. Finally, engage in the heated debate over shifting from DEI to a new framework prioritizing merit and excellence, stirring controversy in the tech landscape.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Desert Camping Mishap

  • Haje went camping in the desert in 115-degree Fahrenheit heat.
  • He ultimately retreated to an air-conditioned hotel.
INSIGHT

AI-Powered Drug Development

  • Formation Bio, an AI drug development startup, raised $372M in Series D funding.
  • Their AI tech aims to accelerate drug development and reduce costs by predicting efficacy and toxicity.
INSIGHT

VW and Rivian Partnership

  • Volkswagen Group invested $1B in Rivian as part of a software development deal.
  • The partnership aims to improve VW's software for electric vehicles, leveraging Rivian's expertise.
Get the Snipd Podcast app to discover more snips from this episode
Get the app